MedPath

Discriminatory values of the citrulline generation test (CGT) following enteral and intravenous administration of glutamine-alanine in stable ICU patients.

Completed
Conditions
stabiele intensive care patienten met allerlei onderliggende aandoeningen
malabsorption
small bowel (enterocyte) function
Registration Number
NL-OMON31306
Lead Sponsor
Vrije Universiteit Medisch Centrum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
12
Inclusion Criteria

1. age between 18-80
2. informed consent
3. fecal production< 250 gr/24 hrs
4. stable ICU patient
5. full enteral nutrition

Exclusion Criteria

no signs of malabsorption, liver cirrhosis, steroids (> 10 mg/dag), pregnancy, partenteral nutrition

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>The determination of discriminatory CGT values in *stable* ICU patients who<br /><br>are able to tolerate enteral nutrition meeting their full protein-energy<br /><br>requirements<br /><br><br /><br><br /><br>enteral enery losses (using bomb calorimetry)</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>The determination of the effects of enteral and intravenous glutamine<br /><br>administration on CGT values in these patients.<br /><br><br /><br>The assessment of differences in plasma citrulline concentrations following<br /><br>venous and arterial blood sampling, respectively</p><br>
© Copyright 2025. All Rights Reserved by MedPath